Tinea versicolor (i.e. Pityriasis versicolor) is a common superficial fungal infection. Patients with this disorder often show symptoms of hypopigmented, hyperpigmented, or erythematous macules on the trunk and proximal upper extremities. Unlike other disorders utilizing the term Tinea (e.g., Tinea pedis, Tinea capitis), Tinea Versicolor is a very common infection which is very difficult to cure but yet mostly ignored. Tinea versicolor is caused by the dimorphic, lipophilic organisms in the genus Malassezia, formerly known as Pityrosporum. The yeast causing the infection very often lives harmlessly in the skin of most adults. Among the symptoms of Tinea is a mild form of eczema that produces mild, patchy lightening of the face, shoulders, or torso. Its distribution is normally parallel to that of the sebaceous glands, with higher occurrence on the thorax, back and face. The infection has worldwide occurrence, its frequency is variable and depends on different climatic, occupational and socio-economic conditions. Tinea versicolor responds well to medical therapy, but recurrence is common and long-term prophylactic therapy may be necessary. The pathophysiology, clinical features, diagnosis, and management as well as prevention of Tinea versicolor were reviewed in this paper. Keywords; Infection, pathophysiology, diagnosis, prevalent, treatment INTRODUCTION Tinea versicolor also known as dermatomycosis furfuracea, Pityriasis versicolor and Tinea flava [1] is a condition characterized by a skin eruption on the trunk and proximal extremities. Recent research has shown that the majority of Tinea versicolor is caused by the Malassezia globosa fungus, although Malassezia furfur is also responsible for a small number of cases [2]. These yeasts are normally found on the human skin and only become troublesome under certain circumstances, such as a warm and humid environment, although the exact conditions that cause initiation of the disease process are poorly understood [3]. The condition Pityriasis versicolor was first identified in 1846 [4]. Versicolor comes from the Latin word “versāre” to change colour. Skin infections are very common in childhood worldwide and between 49 80.4% of African school children are affected [5]. It has been observed to be common in adolescent and young adult males in hot climates [6]. The prevalence of fungal skin infection is about 20% among the American populations at any given time in addition to Ethiopia, 49.2% and Taiwan, 28.2% [7]. Skin infections have been reported to be a major problem in Tanzania where about 34.7% of the International Journal of Scientific Engineering and Applied Science (IJSEAS) – Volume-2, Issue-1, January 2016 ISSN: 2395-3470 www.ijseas.com 202 rural populations have skin diseases [8],[9]. In Nigeria, the prevalence rate is about 40.4% among pupils in primary schools [10]. Clinical investigations have shown that, dermatophytosis of Tinea versicolor and Tinea corporis are responsible for more than 15% of all skin infections in Nigeria [11]. An increase in the prevalence of T. versicolor, among others, was once recorded in the University College Hospital (UCH), Ibadan, between 1994 and 1998 [11]. Poor socioeconomic status was identified as the major cause of skin infections in the developing countries [12]. T. versicolor (Synonym Pityriasis versicolor) is a common, innocuous and chronic fungal infection of the stratum corneum caused by the dimorphic yeast Malassezia furfur. The synonyms Pityrosporum ovale and P. orbiculare were used previously to identify the causal organism. The common sites for the appearance of symptoms on the human body include the chest, neck, back, upper and lower arms. The infection is associated with persistent patches of discoloured skin portions, sharp edges, fine scales and sometimes accompanied by body itching. The predisposing factors to infection include a warm, humid environment, excessive sweating, occlusion, high plasma cortisol levels, immunosuppression, malnourishment and genetically determined susceptibility [13]. Most infections of dermatophytosis are usually treated with drugs e.g. Clotrimazole, Ketoconazole, Fluconazole, Itraconazole, etc.[14]. These drugs are relatively expensive and mostly unaffordable by people with low socio-economic status, who invariably form the bulk of people with skin infections. Both rural and urban residents in the tropical regions, with pronounced Tinea infections, usually resort to herbal remedies that are sourced locally from their native environments. Herbal preparations such as poultices, ointments and soaps have been applied by 65% of patients with eczema, seborrhoiec dermatitis, impetigo, T. capitis and scabies before attending orthodox hospitals [15]. [16] and[17] reported that leaf juice and decoctions of S. alata are used in the treatment of ringworm and other skin diseases in many parts of Nigeria. Among several plant species used in the treatment of skin infection locally without any reported risk or allergic reaction is S. alata (L) Roxb-Caesalpinaceae (formally Leguminosae). Pityriasis versicolor (PV), also known as Tinea versicolor, is one of the most common superficial fungal infections worldwide, particularly in tropical climates. PV is difficult to cure and the chances for relapse or recurrent infections are high due to the presence of Malassezia in the normal skin flora. This review focuses on the clinical evidence, treatment and contemporary status of Tinea versicolor in some countries. The aim of this study is to review the status of Tinea versicolor in some parts of the world. Pathophysiology Tinea versicolor is caused by the dimorphic, lipophilic organisms in the genus Malassezia, formerly known as Pityrosporum. Eleven species are recognized within this classification of yeasts, of which Malassezia globosa and Malassezia furfur are the predominant species isolated in Tinea versicolor [18],[19]. Malassezia is extremely difficult to propagate in laboratory culture and is culturable only in media enriched with C12to C14-sized fatty acids. Malassezia is naturally found on the skin surfaces of many animals, including humans. Indeed, it can be isolated in 18% of infants and 90-100% of adults. The organism can be found on healthy skin and on skin regions demonstrating cutaneous disease. In patients with clinical disease, the organism is found in both the yeast (spore) stage and the filamentous (hyphal) form. Factors that lead to the conversion of the saprophytic yeast to the parasitic, mycelial morphologic form includes genetic predisposition; Warm, humid environments, immunosuppression, malnutrition International Journal of Scientific Engineering and Applied Science (IJSEAS) – Volume-2, Issue-1, January 2016 ISSN: 2395-3470 www.ijseas.com 203 and Cushing syndrome. Human peptide cathelicidin LL-37 plays a role in skin defence against this organism. Even though Malassezia is a component of the normal flora, it can also be an opportunistic pathogen. The organism is considered to be a factor in other cutaneous diseases, including Pityrosporum folliculitis, confluent and reticulate papillomatosis, seborrheic dermatitis, and some forms of atopic dermatitis. Malassezia species have also been shown to be a pulmonary pathogen in patients with immunosuppression due to stem cell transplantation [20]. Causes of Tinea versicolor Tinea versicolor is caused by yeast called Malassezia furfur that normally live on the skin of most adults without causing problems. It exists in two forms, one of which can cause patches of discoloured slightly scaly skin. Factors that induce the disease are poorly understood, but high humidity and immune changes may play roles [20]. Most people with this condition are perfectly healthy. Because the Tinea versicolor fungus is part of the normal adult skin flora, this condition is not contagious. It often recurs after treatment, but usually not right away, so that treatment may need to be repeated only every year or two. Tinea versicolor patches that are brown or reddish-brown go right away after treatment. This fungus produces a chemical, which seems to inhibit the normal production of pigment in the skin resulting in areas of lighter skin. It may take several months for overall colour to even out. It always eventually does. Tinea versicolor does not leave permanent skin discoloration. M. furfur is now the most commonly accepted name for the organism causing Tinea versicolor. Thus, P. orbiculare, P. ovale and M. ovalis are synonyms for M. furfur. Despite disagreement about the names, Tinea versicolor results from a shift in the relationship between a human and a resident yeast flora. Yeasts of the genus Malassezia are known to be members of the skin microflora of human and other warm-blooded vertebrates [21],[22]. These lipophilic yeasts are associated with various human diseases, especially Pityriasis versicolor, a chronic superficial scaling dermatomycosis [23]. The genus of Malassezia has undergone several taxonomic revisions [24]. Later, [25] discovered that there were indeed multiple species which they reclassified and named the genus as Malassezia with several distinct species. Currently there are 11 recognised species viz: 1. M. furfur, [18],[26] 2. M. pachydermatis, 3. M. sympodialis [27] 4. M. globosa [28],[29],[30],[31][22] 5. M. obtuse 6. M. restricta 7. M. slooffiae [25] 8. M. dermatis 9. M. equi 10. M. nana [32],[33] 11. M. japonica[32]
[1]
T. Einarson,et al.
An Overview of Topical Antifungal Therapy in Dermatomycoses
,
1998,
Drugs.
[2]
Mahendra Kumar Rai,et al.
Tinea Versicolor - An Epidemiology
,
2009
.
[3]
V. Morrison,et al.
Malassezia: is it a pulmonary pathogen in the stem cell transplant population?
,
2009,
Transplant infectious disease : an official journal of the Transplantation Society.
[4]
K. Bramono,et al.
Identification of Malassezia species from pityriasis versicolor in Indonesia and its relationship with clinical characteristics
,
2009,
Mycoses.
[5]
L. L. Barrera‐Necha,et al.
In vitro antifungal activity of essential oils and their compounds on mycelial growth of Fusarium oxysporum f. sp. gladioli (Massey) Snyder and Hansen.
,
2009
.
[6]
R. Moniri,et al.
ISOLATION AND IDENTIFICATION OF MALASSEZIA SPP. IN PYTIRIASIS VERSICOLOR IN KASHAN, IRAN
,
2009
.
[7]
M. Shafiquzzaman,et al.
A study to evaluate the efficacy and safety of oral fluconazole in the treatment of tinea versicolor.
,
2009,
Mymensingh medical journal : MMJ.
[8]
Â. Pinto,et al.
Antimicrobial activity of Brazilian copaiba oils obtained from different species of the Copaifera genus.
,
2008,
Memorias do Instituto Oswaldo Cruz.
[9]
C. Rezende,et al.
Antifungal activity of the essential oil from Calendula officinalis L. (asteraceae) growing in Brazil
,
2008,
Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology].
[10]
W. Cunha,et al.
Antimicrobial Activity of the Extract and Isolated Compounds from Baccharis dracunculifolia D. C. (Asteraceae)
,
2008,
Zeitschrift fur Naturforschung. C, Journal of biosciences.
[11]
F. Xiao,et al.
The genetic epidemiology of tinea versicolor in China
,
2007,
Mycoses.
[12]
F. Ajose,et al.
Some Nigerian plants of dermatologic importance
,
2007,
International journal of dermatology.
[13]
N. Morishita,et al.
Microreview of Pityriasis versicolor and Malassezia species
,
2006,
Mycopathologia.
[14]
E. Alexopoulos,et al.
Distribution of Malassezia species in pityriasis versicolor and seborrhoeic dermatitis in Greece. Typing of the major pityriasis versicolor isolate M. globosa
,
2006,
The British journal of dermatology.
[15]
V. Crespo-Erchiga,et al.
Malassezia yeasts and pityriasis versicolor
,
2006,
Current opinion in infectious diseases.
[16]
F. Şahin,et al.
Biological Activities of the Essential Oil and Methanol Extract of Achillea biebersteinii Afan. (Asteraceae)
,
2006
.
[17]
O. Onayemi,et al.
Parental Factors Influencing the Prevalence of Skin Infections and Infestations Among Nigerian Primary School Pupils
,
2005
.
[18]
M. Ram,et al.
Pityriasis versicolor in the pediatric age group.
,
2005,
Indian journal of dermatology, venereology and leprology.
[19]
T. Sugita,et al.
Antifungal Activities of Tacrolimus and Azole Agents against the Eleven Currently Accepted Malassezia Species
,
2005,
Journal of Clinical Microbiology.
[20]
E. Owoaje,et al.
Prevalence of Skin Disorders in School Children in Ibadan, Nigeria
,
2005,
Pediatric dermatology.
[21]
A. Fleischer,et al.
Treatment of pityriasis versicolor in the United States
,
2004,
The Journal of dermatological treatment.
[22]
H. Zeraati,et al.
Study of the distribution of Malassezia species in patients with pityriasis versicolor and healthy individuals in Tehran, Iran
,
2004,
BMC dermatology.
[23]
A. Hasegawa,et al.
Malassezia nana sp. nov., a novel lipid-dependent yeast species isolated from animals.
,
2004,
International journal of systematic and evolutionary microbiology.
[24]
E. Guého,et al.
The genus Malassezia with description of four new species
,
1996,
Antonie van Leeuwenhoek.
[25]
A. Rezusta,et al.
Isolation of Malassezia globosa and M. sympodialis from patients with pityriasis versicolor in Spain
,
2004,
Mycopathologia.
[26]
A. Palit,et al.
The genus Malassezia and human disease.
,
2003,
Indian journal of dermatology, venereology and leprology.
[27]
R. Summerbell,et al.
Pityriasis versicolor
,
2002,
Journal of the European Academy of Dermatology and Venereology : JEADV.
[28]
S. Dutta,et al.
Pityriasis versicolor: socioeconomic and clinico‐mycologic study in India
,
2002,
International journal of dermatology.
[29]
H. Suto,et al.
New Yeast Species, Malassezia dermatis, Isolated from Patients with Atopic Dermatitis
,
2002,
Journal of Clinical Microbiology.
[30]
O. Onayemi,et al.
A prevalence survey of skin diseases in Nigerian children.
,
2001,
Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria.
[31]
Á. Vera Casaño,et al.
Malassezia globosa as the causative agent of pityriasis versicolor
,
2000,
The British journal of dermatology.
[32]
J. Guillot,et al.
Identification of Malassezia species isolated from patients with seborrhoeic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects.
,
2000,
Medical mycology.
[33]
H. Yamaguchi,et al.
Species identification and strain typing of Malassezia species stock strains and clinical isolates based on the DNA sequences of nuclear ribosomal internal transcribed spacer 1 regions.
,
2000,
Journal of medical microbiology.
[34]
B. Leppard,et al.
Prevalence of skin disease in rural Tanzania and factors influencing the choice of health care, modern or traditional.
,
1998,
Archives of dermatology.
[35]
T. Nishikawa,et al.
Pityriasis versicolor with a unique clinical appearance.
,
1998,
Medical mycology.
[36]
M. L. O'Dell.
Skin and wound infections: an overview.
,
1998,
American family physician.
[37]
Peter J. Sunenshine,et al.
Tinea versicolor.
,
1998,
International journal of dermatology.
[38]
I. V. Sankara Rao,et al.
Oral fluconazole in tinea versicolor.
,
1997,
Indian journal of dermatology, venereology and leprology.
[39]
R. Savin.
Diagnosis and treatment of tinea versicolor.
,
1996,
The Journal of family practice.
[40]
B. Elewski.
Cutaneous mycoses in children
,
1996,
The British journal of dermatology.
[41]
N. Levine,et al.
Fungal skin infections: common but stubborn
,
1994
.
[42]
L. Bélec,et al.
Pityriasis versicolor in the Central African Republic: a randomized study of 144 cases.
,
1991,
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.
[43]
P. Jacobs,et al.
Tinea versicolor: epidemiologic, clinical, and therapeutic aspects.
,
1991,
Journal of the American Academy of Dermatology.
[44]
A. Oriani,et al.
Pityriasis versicolor of the face
,
1991,
Mycoses.
[45]
M. Dagnew,et al.
Epidemiology of common transmissible skin diseases among primary school children in north-west Ethiopia.
,
1991,
Tropical and geographical medicine.
[46]
M. Abatan.
A note on the anti-inflammatory action of plants of some Cassia species.
,
1990
.
[47]
K. T. Holland,et al.
The distribution and ecology of Malassezia furfur and cutaneous bacteria on human skin.
,
1989,
The Journal of applied bacteriology.
[48]
S. Klotz.
Malassezia furfur.
,
1989,
Infectious disease clinics of North America.
[49]
P. Jacobs,et al.
Tinea versicolor: treatment and prophylaxis with monthly administration of ketoconazole.
,
1984,
Cutis.
[50]
Maheswari.
Clinical and Epidemiological Studies on Tinea Versicolor in Kerala
,
1978
.